Rockford woman is 1st in Wisconsin to receive newly-approved FDA ALS treatment
-
2:51
How Wisconsin’s Democratic chair seeks to change national approach...
-
2:05
Mukwonago measure to issue citations to students who violate...
-
1:49
SCOUS signals states can decide gender affirming care bans, Wisconsin...
-
2:13
Players react after WIAA admits error revealing Greenfield and...
-
2:15
New raised crosswalks in Milwaukee catch some drivers by surprise,...
-
1:18
$1,000,000 Mega Millions ticket sold at El Rey Food Mart in Milwaukee
-
0:44
$30K donation to go toward new innovation lab, bridging digital...
-
1:42
December night sky
-
1:36
Inside Larry’s Market in Brown Deer: Appetizer and cocktail...
-
2:18
Winter returns with snow showers, a wind advisory and a blast...
-
2:43
Visit Milwaukee previews December’s lineup of festive fun
-
5:14
Local expert answers parents’ education questions
ROCKFORD, Ill. (CBS 58) -- A Rockford, Illinois woman is the first in Wisconsin to receive a new FDA-approved treatment for ALS, or Lou Gehrig's disease.
Michelle Francis was first diagnosed in 2019 with what's called the SOD1 mutation.
The disease has run in her family for seven generations, affecting 65 members and counting.
In April, UW Health in Madison offered a glimmer of hope -- a monthly treatment involved removing spinal fluid with a needle and replacing it with a new drug.
Now, nearly eight appointments later, Francis says she has hope for the first time.
"It will be here forever so we definitely have to have something to once you develop, there's some hope and I’m thinking this is gonna be it," said Francis.
Francis says she hopes others with ALS will hear her story, be inspired, and most importantly, not give up.